---
title: "Eukaryotic pol ζ/Rev1 complex drives CG-to-GC transversions and large mutator effect"
id: "biorxiv-1-minimal-eukaryotic-dna-polymerase-zeta-rev1-gc-pair-mutasome"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-1-minimal-eukaryotic-dna-polymerase-zeta-rev1-gc-pair-mutasome"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1?rss=1"
published_at: "2026-11-21T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Eukaryotic pol ζ/Rev1 complex drives CG-to-GC transversions and large mutator effect
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-1-minimal-eukaryotic-dna-polymerase-zeta-rev1-gc-pair-mutasome
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1?rss=1)
- **Published At:** 2026-11-21T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study examined the mutagenic consequences of elevated eukaryotic translesion synthesis (TLS) polymerase activity, focusing on the multi-subunit **pol ζ** complex and its partner **Rev1**. - Investigators reported that overproduction of the five-subunit **pol zeta5** complex increases spontaneous mutation rates by up to 20-fold; overproduction of Rev1 alone or a four-subunit complex lacking Rev1 did not produce this effect. - The pol zeta5 complex studied contains Rev3 (catalytic subunit), Rev1 (TLS polymerase), a Rev7 dimer, and the Pol31/Pol32 subunits shared with replicative Pol δ; Pol31/Pol32 bind Rev3’s Fe-S-containing C-terminal domain (CTD), which normally acts as an assembly hub. - Data indicated that pol zeta5 can access undamaged, replicating DNA and compete with replicative polymerases; this mutator activity occurred independently of PCNA ubiquitylation. - Exposure to hydroxyurea augmented the mutator effect, and pol zeta5 overproduction synergized with defects in DNA mismatch repair to increase mutagenesis. - A pol zeta5 complex containing CTD-truncated Rev3 retained mutagenic activity, showing that active TLS complexes can assemble and function without the canonical CTD interaction hub. - Both full and CTD-truncated pol zeta5 complexes predominantly generated **CG-to-GC transversions**; the authors noted similarity of this pattern to some COSMIC cancer mutational signatures. - Inactivation of Rev3 catalytic activity abolished the mutagenic phenotype; conversely, loss of Rev1 catalytic activity substantially reduced mutation rates and eliminated CG-to-GC transversions, implicating **Rev1** as the primary driver of that substitution pattern. - The preprint emphasizes implications for cellular evolution and cancer development but is not peer-reviewed; experimental details (specific assays, strains, exact expression systems, and quantitative methods) are not reported in the abstract and would require consultation of the full manuscript or supplementary materials for complete methodological transparency.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=mR_nq8qv4whjdlwuAelCvs7O9g_.Y73L1R_.goGOIaw-1795305280.9218128-1.2.1.1-OJB7lEzMALTCop4oxXByL64mm5chPHHWBPRfI5sP2ZFIf67ohKYf6wgLvX4PMxOo) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Minimal eukaryotic DNA polymerase zeta/Rev1 GC-pair mutasome Charlie T McNellis, Morgan Brown, Dmitrii D Panteleev, Anna S Zhuk, Anna Y Aksenova, [ View ORCID Profile](http://orcid.org/0000-0003-1179-5796)Youri i. I. Pavlov doi: https://doi.org/10.64898/2026.11.20.768204 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Charlie T McNellis 1 University of Nebraska Medical Center; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Charlie%2BT%2BMcNellis%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=McNellis%20CT&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ACharlie%2BT%2BMcNellis%2B) Morgan Brown 2 University of Nebraska Medical Center; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Morgan%2BBrown%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Brown%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMorgan%2BBrown%2B) Dmitrii D Panteleev 3 Institute of Applied Computer Science, ITMO University, 197101, St. Petersburg, Russia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dmitrii%2BD%2BPanteleev%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Panteleev%20DD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADmitrii%2BD%2BPanteleev%2B) Anna S Zhuk 3 Institute of Applied Computer Science, ITMO University, 197101, St. Petersburg, Russia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BS%2BZhuk%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Zhuk%20AS&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAnna%2BS%2BZhuk%2B) Anna Y Aksenova 4 Vavilov Institute of General Genetics, St. Petersburg Branch, Russian Academy of Sciences, 199034 St. Petersburg, Russia; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BY%2BAksenova%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Aksenova%20AY&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAnna%2BY%2BAksenova%2B) Youri i. I. Pavlov 5 Eppley Institute, University of Nebraska Medical Center, Omaha, NE, USA * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Youri%2Bi.%2BI.%2BPavlov%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Pavlov%20YI&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYouri%2Bi.%2BI.%2BPavlov%2B) * [ORCID record for Youri i. I. Pavlov](http://orcid.org/0000-0003-1179-5796 "Open in new tab") * For correspondence: ypavlov@unmc.edu * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5986155/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5986155/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5986155/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5986155/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5986155/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5986155/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract In eukaryotes, translesion DNA synthesis (TLS) enables replication across DNA lesions, difficult DNA structures, and during replicative stress. While TLS prevents replication fork collapse, it is inherently mutagenic and requires tight regulation to prevent global mutation rates increase. Here, we show that elevated DNA polymerase pol ζ/Rev1 promotes spontaneous mutagenesis during replication. The five subunits of pol zeta complex (pol zeta5) are the catalytic subunit Rev3, the TLS polymerase Rev1, a dimer of accessory protein Rev7, the Pol31 and Pol32 subunits shared with replicative pol delta. Pol31 and Pol32 bind the Fe-S-containing C-terminal domain (CTD) of Rev3, which serves as a major assembly hub. We found that overproduction of pol zeta5₅, but not four-subunit pol zeta4 lacking Rev1 or Rev1 alone, increases spontaneous mutation rates by up to 20-fold, indicating that pol zeta5 can access undamaged DNA during replication and compete with replicative DNA polymerases. This mutator effect is independent of PCNA ubiquitylation. augments by hydroxyurea and synergizes with DNA mismatch repair defects. Overproduction of a pol zeta5 complex containing CTD-truncated Rev3 is also mutagenic, demonstrating that active TLS complexes can assemble and function without the canonical CTD interaction hub. Both complexes predominantly generate CG-to-GC transversions, a mutational pattern that resembles several COSMIC cancer mutational signatures. Inactivating Rev3 catalytic activity abolishes mutagenesis, whereas loss of Rev1 catalytic activity substantially reduces mutation rates and eliminates CG-to-GC transversions, identifying Rev1 as the primary cause of the observed mutation pattern. The findings reveal previously unrecognized mechanisms of pol zeta-dependent mutagenesis with broad implications for cellular evolution and cancer development ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * ## Funder Information Declared NE DHHS, 2023-46 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.20.768213v1 "Chemolithoautotrophic acidophile phenotyping by measuring metabolic byproduct formation in microplates") Posted November 21, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/21/2026.11.20.768204.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.20.768204v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/11/21/2026.11.20.768204.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Minimal eukaryotic DNA polymerase zeta/Rev1 GC-pair mutasome Charlie T McNellis, Morgan Brown, Dmitrii D Panteleev, Anna S Zhuk, Anna Y Aksenova, Youri i. I. Pavlov bioRxiv 2026.11.20.768204; doi: https://doi.org/10.64898/2026.11.20.768204 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.20.768204v1%26text%3DMinimal%2520eukaryotic%2520DNA%2520polymerase%2520zeta%2FRev1%2520GC-pair%2520mutasome "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.20.768204v1%26t%3DMinimal%2520eukaryotic%2520DNA%2520polymerase%2520zeta%2FRev1%2520GC-pair%2520mutasome "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.20.768204v1%26title%3DMinimal%2520eukaryotic%2520DNA%2520polymerase%2520zeta%2FRev1%2520GC-pair%2520mutasome%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.20.768204v1%26title%3DMinimal%2520eukaryotic%2520DNA%2520polymerase%2520zeta%2FRev1%2520GC-pair%2520mutasome "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.20.768204) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.20.768204v1&count=horizontal&via=&text=Minimal%20eukaryotic%20DNA%20polymerase%20zeta/Rev1%20GC-pair%20mutasome&counturl=www.biorxiv.org/content/10.64898/2026.11.20.768204v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.bi
## Related Clinical Research

- [LCatlas: Point-of-Care Prediction Tool for Immunotherapy Response in NSCLC](https://medichelpline.com/clinical-feed/medrxiv-19-lcatlas-a-point-of-care-tool-for-predicting-immunotherapy-outcomes-in-non-small.md)
- [Spatial metabolic ecosystems in **IDH-mutant glioma** — preprint report and open questions](https://medichelpline.com/clinical-feed/biorxiv-10-spatial-metabolic-ecosystems-shape-the-architecture-of-idh-mutant-glioma.md)
- [SLC6A8 creatine transporter identified as an immune pressure–exposed metabolic vulnerability in ac](https://medichelpline.com/clinical-feed/biorxiv-0-the-creatine-transporter-slc6a8-is-an-immune-pressure-exposed-metabolic.md)
- [Context-dependent roles of DJ-1 (PARK7) in oxidative-stress diseases: neuroprotection versus tumor](https://medichelpline.com/clinical-feed/pubmed-43059404.md) (DOI: 10.3892/mmr.2026.14076)
- [Mucosal clonal CAR+ T cell expansion drives enterocolitis after BCMA CAR-T (cilta-cel)](https://medichelpline.com/clinical-feed/nature-1-expansion-and-cytotoxicity-of-mucosal-car-t-cells-in-enterocolitis-associated.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.